Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glimestar-PM2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimestar-PM2 Tablet ER

Diabetic patients with type 2 mellitus can benefit from Glimestar-PM2 ER tablets, a dual-action medication designed to regulate blood glucose. This medication complements diet and exercise, enhancing blood sugar management in adults. Its mechanism involves improved insulin utilization, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and frequency for Glimestar-PM2 ER, taking it with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dose. Excessive intake can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption as it can heighten the risk of adverse effects.

Uses of Glimestar-PM2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimestar-PM2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimestar-PM2 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume with food.

Common Side effects of Glimestar-PM2 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimestar-PM2 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimestar-PM2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glimestar-PM2 Tablet ER works:

Glimestar-PM2 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimestar-PM2 ER tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimestar-PM2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimestar-PM2 tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimestar-PM2 Tablet ER; dosage modification may be necessary. Consult your physician for guidance. Glimestar-PM2 Tablet ER is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should use Glimestar-PM2 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised. Glimestar-PM2 Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Glimestar-PM2 Tablet ER :

Should you forget a Glimestar-PM2 Extended-Release Tablet, take it immediately if remembered. However, near the time for your next dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimestar-PM2 Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimestar-PM2 Tablet ER

Consuming alcohol while taking Glimestar-PM2 Tablet ER is unsafe. Alcohol can reduce blood sugar levels (causing hypoglycemia) and heighten the risk of lactic acidosis.
Tell your doctor before taking Glimestar-PM2 Tablet ER if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you take, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Glimestar-PM2 Tablet ER, containing metformin, can lead to vitamin B12 deficiency. Prolonged use impairs the stomach's absorption of this vitamin.
Glimestar-PM2 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a readily available sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glimestar-PM2 Tablet ER
103
MRP 125
17% off